Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013
Weight Change and Antiepileptic Drugs. Health Issues and Criteria for Appropriate Selection of an Antiepileptic Agent.
The Neurologist 12:163-167, Biton,V., 2006
Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001
Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000
Drug-Induced Pseudolymphoma Secondary to Lamotrigine
Neurol 50:1509-1510, Pathak,P.&McLachlan,R.S., 1998
Obesity and Endocrine Disorders in Women Taking Valproate for Epilepsy
Ann Neurol 39:579-584, 5591996., Isojarvi,J.I.T.,et al, 1996
Carbamazepine Hypersensitivity Syndrome:Report of 4 Cases & Review of Literature
Medicine 74:144-151, DeVriese,A.S.P.,et al, 1995
Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995
Vigabatrin in the Treatment of Epilepsy:A Long-Term Follow-Up Study
JNNP 52:467-471, Tartara,A.,et al, 1989
Fetal Hydantoin Syndrome, Neuroblastoma, & Hemorrhagic Disease in a Neonate
Jr. , et al, JAMA 244:1464-146580., Allen,R.W., 1980
Mucocutaneous Eruptions Due to Antiepileptic Drug Therapy in Children
Ann Neurol 5:262-267, Pollack,M.A.,et al, 1979
Phenytoin Hypersensitivity:38 Cases
Neurol 29:1480-1485, Harunda,F., 1979
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979